Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you had to choose, do you think we hit the lower target or upper target first?
Article states tutes own only 11.59%. That's not correct.
If rare diseases are the fastest way to approval then why didn't we start a trial for a rare disease 18 months ago? Based on the timetable, we would have been approved over 5 months ago and then prescribed for off-label for AD related insomnia.
If the results are as profound as most of us believe then why the need to spend so much time to optimize the trial? If it solves insomnia then enroll all patients who can't sleep and have that as a milestone.
I also wonder if the data mining is due to the 15 month data not being as stellar as the 57 week data? I know I'll catch shxt for this, it is taking a long time to get the next phase of AD going. If things are just the tip of the iceberg, then I say lets hire the right people and control our destiny. I think the lack of progress is due to everything being done by others. Yes, it's less expensive short term, however I believe it adds months and months to trial completion.
Where is the patent news? Are we waiting for our outsourced Legal team to review?
I sense all my questions will be answered by end of year. Sooner would be great.
And Biogen is still mentioned on slide 23 for MS.
You think 1B would go with the shareholder rights plan in hand?
I said Merck but meant Pfizer. Merck is in another company in invested in.
I wonder since the various foundations are funding the trials are they imposing any stipulations about limits on pricing if and when the drug gets approved?
Talon - I actually think Merck is in the game. Wouldn't it be something if Biogen and Merck formed a partnership with the sole purpose of buying us out? Independently, coughing up $10B may be difficult to swallow, however, if they create a partnership and each contribute $5B, then that may appease their shareholders due to less risk and provide assurances in that somebody else believes there is value in the $10B investment. Dang, let's add a third party and up the ante to $15B!!
Why not?
And I believe Rett was to start sometime in Q2 however the last 10K states trials wouldn't start until second half. If you call IR they will always refer you to the latest SEC filings. A surprise would be nice but I'm getting too old to expect it early. :)
News about trials starting won't be until Sept. is my guess. I would love to hear about it sooner but things don't seem to move that fast. IMO, the challenge is we are always waiting on others to kick the can down the street. Less than a dozen ee's means lots of stuff is "outsourced" to non-profit organizations and perhaps their are also lacking on manpower to drive results quicker. I wish I had the huevos to sell covered calls and pick up a little income while we wait. I've been here too long to risk hearing news earlier than expected. I hope and I wish I'm wrong. Time will tell. In the meantime, tutes will most likely add another 5%+ to their holdings this quarter and next.
Day half over and the big bid at 5.80 is now less than half the size
Also it looks like someone is selling the June 7.5 calls (covered call?).
Most likely no news until sept. Is my guess.
That's nice to see. Hope it's real. 5.85 to 5.93 appears to have a lot for sale. As light as the volume has been it may take all day to get to 6.00.
It's down on no volume. Most likely the author of last week's SA article helping his cause.
For us believers, today's news is not that profound. If you believe it works based on previous preclinicals, then today news is just confirmation of what we already know. It works!!
What is going on with the patent? My guess is we will stay in the 5.50 to 6.00 channel for another couple weeks without news. I hope this is not a boring summer. Boring defined as no significant news.
So, should we expect 6 month data on the "new" trail vs 18 on the old?
We can only say that for so long. At last count, we been speculating such for 3+ months. Time is very near. We need to hear something profound.
With all the stars aligning, we should be hearing some great news soon (weeks)???
The best time to buy is now. positive PIII results eventual buyout. money in the bank
So he thinks he can make $4 if it hits his 75m MC. How short is he? 100 shares? He was digging, going back many years, attempting to boast his reason for being short.
One way to prove him wrong is to release some good data. We are overdue. Now would be a perfect time. Let's see the 15 and 18 month data.
It's an arbitrary date. I'm just thinking investors will get itchy if we don't hear anything in a couple of weeks. It may be 3 or 4 weeks but at some point people want to hear something and if we don't I feel the short term holders will sell.
I'm still holding my 1,000 trading shares I bought at 5.90. LOL!!
Hi Tom, it seems to me once the charts take a bearish tone we pop a little and just when it seems we may be in a billets cycle we go down.
I say we drift between 5.50 and 6.00 for another couple of weeks while we anticipate news. If no news by the week of June 5th, then I say we can drop to test the 4.95 by mid June.
Let's hope we hear something powerful in the next several weeks.
Agreed. After my last post I went back and reread and noticed the date (Feb 2016). So perhaps it means if data is consistent at time of application and last year's data when orphan status was requested.
Perhaps. It kind of read to me like conditional approval, where you get to go to market but have to continue validating with trial results. It doesn't say "at the time of application" it says "at the time of marketing authorization".
You may be right! What I was thinking, they submit data at the time of application and since the application can take six months they need to submit the (latest) data again at the authorization meeting (if there is a meeting) to ensure the data is consistent to what was previously provided. In any event, it seems like we are further along then most thought. Perhaps the reason for today's move with above average volume.
This assumption will need to be confirmed at the time of marketing authorisation, in order to maintain the orphan status
Perhaps it means we need to provide the latest trial updates a week prior to decision meeting to ensure current data is good as of the date of EMA submission. Just a guess.
I think it will come in shortly after we file with EMA. I doubt we will get a PR on the submission but will upon decision. My guess we will file by 7/1 and hope to hear about partner by 7/31.
This is one thing that makes me question their fairness. They wait until 10k is filed then issue options. Now we have to wait a full year to learn why. I'm certain they knew the options were going to be rewarded so why not disclose in this year's filing?
Also, the options awards are on an irregular schedule so it appears they are tied to some milestone. I don't object the awards, I would like to know what they were for? What milestone was reached? Was it recent patent? If so, then where is the patent PR? If patent milestone is significant then it should be in a PR. Things have been too quiet too long. The best argument for a good value partnership is to release data and get share price up. Higher share price equals higher partnership value.
Releasing data is not detriment partnership value. It's time.
Some offers at 8.50 Can we get past it?
Volume above 10 and 90 day average. Some strength last few minutes. Trading at highs of day. Would be nice to hear some news.
I use to work for a large corp (top 100) and we used the same tactic. The biggest benefit was it looked at all positions and adjusted salary/comp accordingly and reduced turnover significantly. Retaining ee's especially when you are small like ADXS goes a long way in attaining company goals. It's money well spent.
The real issue is you bought 4 years too early. So please get over it. Shareholder value creation will happen. Just not on your timetable.
And with the "share grab" he is going to be filthy rich while the rest of us just gets plan ol' rich.
Fbg, you're like a women you just can't let go. By the time this does hit you will most likely shorten your life by 20 years and not be able to enjoy the outcome. You need to find peace.
IBB up 1.6% and XBI up 1.9%. Good day for bios.
It would be nice to get back up to 6 today.
Sorry there was 10 patients. I was thinking nine.
It looks to me it was 100%. 8 of 9 complete response at 6 month sigmoidoscopy and #9 didn't have a sigmoidoscopy until one year and was clear.
If I'm not mistaken the latest 10Q says trials will start in 2nd half of 2017. Seems like timetables are always pushed out so I'm not expecting anything until Thanksgiving or later.
Why is it we haven't heard about the patent?
I do. I use to live in Calif. some think Calif will slip into the ocean but I think it will rise 100 ft. When the big one hits.
Yes, yes, yes and no
Let's hope we hit payday before they all happen.
We should be getting a PR right about now on the patent.
Maybe all retail is out but you and me and I doubt the tutes would bother.
If so, once they make it public than we should jump in share price. If BOD is placing that much emphasis on it then, surely the tutes are. Perhaps that's the delay in PR, they needed to get the options awarded first. Hmmmmm!